Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese

Cenobamate (XCOPRI and ONTOZRY) is a novel antiseizure medication for the treatment of focal‐onset seizures. Nonetheless, there is limited information on the pharmacokinetics (PKs), safety, and efficacy of cenobamate in Asian people, including Japanese people. This study aimed to evaluate the PKs an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Eunsol, Sunwoo, Jung, Huh, Ki Young, Kim, Yu Kyong, Lee, SeungHwan, Jang, In‐Jin, Yu, Kyung‐Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841444/
https://www.ncbi.nlm.nih.gov/pubmed/34670008
http://dx.doi.org/10.1111/cts.13167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841444/
https://www.ncbi.nlm.nih.gov/pubmed/34670008
http://dx.doi.org/10.1111/cts.13167

Ejemplares similares